PT1005332E - Composicao farmaceutica para reduzir a producao da proteina mcp-1 - Google Patents

Composicao farmaceutica para reduzir a producao da proteina mcp-1

Info

Publication number
PT1005332E
PT1005332E PT98943862T PT98943862T PT1005332E PT 1005332 E PT1005332 E PT 1005332E PT 98943862 T PT98943862 T PT 98943862T PT 98943862 T PT98943862 T PT 98943862T PT 1005332 E PT1005332 E PT 1005332E
Authority
PT
Portugal
Prior art keywords
reducing
production
pharmaceutical composition
protein mcp
mcp
Prior art date
Application number
PT98943862T
Other languages
English (en)
Inventor
Angelo Guglielmotti
Alberto Mantovani
Original Assignee
Aziende C R Angelini Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende C R Angelini Francesco filed Critical Aziende C R Angelini Francesco
Publication of PT1005332E publication Critical patent/PT1005332E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98943862T 1997-07-28 1998-07-22 Composicao farmaceutica para reduzir a producao da proteina mcp-1 PT1005332E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001789A IT1293795B1 (it) 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1

Publications (1)

Publication Number Publication Date
PT1005332E true PT1005332E (pt) 2004-03-31

Family

ID=11377642

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98943862T PT1005332E (pt) 1997-07-28 1998-07-22 Composicao farmaceutica para reduzir a producao da proteina mcp-1

Country Status (16)

Country Link
US (1) US6534534B1 (pt)
EP (1) EP1005332B1 (pt)
JP (2) JP4651191B2 (pt)
AR (1) AR016382A1 (pt)
AT (1) ATE251902T1 (pt)
AU (1) AU744492B2 (pt)
CA (1) CA2300289C (pt)
DE (1) DE69819012T2 (pt)
DK (1) DK1005332T3 (pt)
ES (1) ES2207858T3 (pt)
HK (1) HK1028561A1 (pt)
IT (1) IT1293795B1 (pt)
PT (1) PT1005332E (pt)
SI (1) SI1005332T1 (pt)
WO (1) WO1999004770A2 (pt)
ZA (1) ZA986636B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
KR101581828B1 (ko) * 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 신규한 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1, ｃｘ3ｃｒ1 및 ｐ40의 발현을 기초로 한 질환들의 치료에서 이의 용도
WO2009109654A2 (en) * 2008-03-07 2009-09-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1
WO2009109616A2 (en) * 2008-03-07 2009-09-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
BR112012002130A2 (pt) 2009-08-03 2015-09-15 Aziende Chimique Riunite Angelini Francesco A C R A F S P A processo para a preparação de composto,e, composto intermediário
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
WO2011106611A2 (en) 2010-02-25 2011-09-01 Prairie Ventures, L.L.C. System and method for anatomical pathology sample handling, storage, and analysis
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP3307068B1 (en) 2015-06-12 2021-08-25 Vettore, LLC Mct4 inhibitors for treating disease
AU2017375960B2 (en) 2016-12-12 2022-03-10 Vettore, LLC Heterocyclic inhibitors of MCT4
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
WO1994009128A1 (en) * 1992-10-22 1994-04-28 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
JPH08333262A (ja) * 1995-04-07 1996-12-17 Chugai Pharmaceut Co Ltd 免疫抑制剤
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
DE19538402A1 (de) * 1995-10-14 1997-04-17 Boehringer Mannheim Gmbh Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel
JPH09165339A (ja) * 1995-10-27 1997-06-24 American Home Prod Corp ラパマイシンを付与したドナー脾細胞を用いる臓器移植の延長
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1

Also Published As

Publication number Publication date
ZA986636B (en) 1999-02-04
ATE251902T1 (de) 2003-11-15
JP4651191B2 (ja) 2011-03-16
CA2300289C (en) 2007-11-20
JP2010047609A (ja) 2010-03-04
CA2300289A1 (en) 1999-02-04
AU9160198A (en) 1999-02-16
AR016382A1 (es) 2001-07-04
US6534534B1 (en) 2003-03-18
WO1999004770A3 (en) 1999-04-15
SI1005332T1 (en) 2004-02-29
HK1028561A1 (en) 2001-02-23
DK1005332T3 (da) 2004-02-09
DE69819012T2 (de) 2004-08-12
EP1005332B1 (en) 2003-10-15
IT1293795B1 (it) 1999-03-10
ITMI971789A1 (it) 1999-01-28
JP5086322B2 (ja) 2012-11-28
ES2207858T3 (es) 2004-06-01
DE69819012D1 (de) 2003-11-20
EP1005332A2 (en) 2000-06-07
AU744492B2 (en) 2002-02-28
WO1999004770A2 (en) 1999-02-04
JP2001510793A (ja) 2001-08-07

Similar Documents

Publication Publication Date Title
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO20004345L (no) Farmasøytisk sammensetning
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
FI955311A (fi) Farmaseuttinen koostumuspohja
ID24654A (id) Formulasi farmasi omeprazola
ID27415A (id) Komposisi farmaseutik
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
PT1005332E (pt) Composicao farmaceutica para reduzir a producao da proteina mcp-1
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
LV11727A (lv) Farmaceitiska kompozicija
BR9507768A (pt) Composição farmacêutica
ID25857A (id) Komposisi farmasi
FI973280A (fi) Farmaseuttinen koostumus
ID26215A (id) Komposisi farmasi
BR9605777A (pt) Composição farmacêutica
PT1171470E (pt) Anticorpos para a proteina placentaria 13
ID23531A (id) Komposisi farmasi
BR9605131A (pt) Composição farmacêutica
SE9402924D0 (sv) Novel pharmaceutical composition
BR1100755A (pt) composição farmacêutica
KR960016881A (ko) 제약 조성물
SE9402437D0 (sv) Pharmaceutical composition